More than half of Americans qualify for GLP-1 receptor agonist drugs, but many can't afford them. Experts share cheaper ...

Bone broth, which is having an inescapable resurgence, is rapidly increasing in popularity, and with good reason. Having ...

The rise of weight loss drugs is not only changing individual lives, but also reshaping large sections of the economy.

Participants in Wegovy clinical trials were more likely to report “severe gastrointestinal adverse reactions,” the FDA's ...

Ozempic promotes weight loss by mimicking the GLP-1 hormone the body naturally produces after eating, so users feel fuller ...

“We are thrilled that today’s findings showed the superior weight loss of Zepbound, which helped patients achieve ... Both drugs are different versions of the diabetes treatments Mounjaro and Ozempic, ...

Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by ...

Lilly said patients taking Zepbound lost about 20% of their weight on average compared to nearly 14% for Wegovy.

Reality star Khloe Kardashian admits that she wishes Ozempic was around when she was trying to lose weight 10 years ago after ...

Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from ...

A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...

SURMOUNT-5’s results reflect those of multiple real-world studies, which have found that tirzepatide treatment results in ...